Publication
6/01/2009
Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.
Pichla-Gollon SL, Lin SW, Hensley SE, Lasaro MO, Herkenhoff-Haut L, Drinker M, Tatsis N, Gao GP, Wilson JM, Ertl HC, Bergelson JM
Journal Of Virology
Publication
2/01/2007
Structure-based identification of a major neutralizing site in an adenovirus hexon.
Pichla-Gollon SL, Drinker M, Zhou X, Xue F, Rux JJ, Gao GP, Wilson JM, Ertl HC, Burnett RM, Bergelson JM
Journal Of Virology
Publication
4/10/2003
Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector.
Varnavski AN, Schlienger K, Bergelson JM, Gao GP, Wilson JM
Human Gene Therapy
Publication
3/01/2002
Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
Xiang Z, Gao G, Reyes-Sandoval A, Cohen CJ, Li Y, Bergelson JM, Wilson JM, Ertl HC
Journal Of Virology
Publication
1/01/2002
Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor.
Cohen CJ, Xiang ZQ, Gao GP, Ertl HC, Wilson JM, Bergelson JM
The Journal Of General Virology